Status:
COMPLETED
Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education
Lead Sponsor:
Hannover Medical School
Conditions:
Lung Transplantation
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Experimental intervention: Patient education after lung transplantation via Tablet computers. An electronic patient questionnaire via tablet computer will be collected in addition. Control intervent...
Detailed Description
Noncompliance with immunosuppressive medications after organ transplantation is thought to be a leading cause of allograft rejection, graft loss, and death. Immunosuppressant medy to prevent graft rej...
Eligibility Criteria
Inclusion
- Patients at least 6 months after lung transplantation (single, double or combined)
- Informed consent
- At least 10 trough levels analyzed in MHH reference lab in last 6 months
- \< 50% of calcineurin inhibitor trough levels in target range in last 6 months in outpatient clinic
Exclusion
- Hospitalization during last 3 months
- BOS stage 3 (FEV1 \< 50% baseline)
- End stage kidney disease (GFR \<15 ml/min/1.73 m2 or renal replacement therapy)
- Oxygen requirement at rest
- Steroid pulse therapy (\>500 mg methylprednisolone per day) during the last 4 weeks
- Illiteracy
- Need for isolation (Colonization with multi. or pan resistant organisms, e.g. MRSA, B. cenocepacia)
- limited German language skills or other reasons which might impair patient communication or computer handling
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01398488
Start Date
July 1 2011
End Date
May 1 2013
Last Update
June 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanover Medical School
Hanover, Lower Saxony, Germany, 30625